Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|July 2, 2021
Therapeutic Development in Charcot Marie Tooth Type 1 DiseasePierre Miniou, Michel Fontes
Glia|December 2, 2011
Connexin 32 is involved in mitosisSaleh Mones, Benoit Bordignon, Michel Fontes
BMC Nephrology|October 20, 2011
High Resolution Melt analysis for mutation screening in PKD1 and PKD2Stanislas Bataille, Yvon Berland, Michel Fontes, et al.
Current Genomics|September 3, 2010
Ascorbic Acid and gene expression: another example of regulation of gene expression by small molecules?Sophie Belin, Ferdinand Kaya, Stéphane Burtey, et al.
Frontiers in Cell and Developmental Biology|November 4, 2014
Ascorbic acid is a dose-dependent inhibitor of adipocyte differentiation, probably by reducing cAMP poolFryad Rahman, Fadi Al Frouh, Benoit Bordignon, et al.
Molecular Nutrition & Food Research|December 14, 2016
Ascorbic acid drives the differentiation of mesoderm-derived embryonic stem cells. Involvement of p38 MAPK/CREB and SVCT2 transporterFryad Rahman, Benoit Bordignon, Raphael Culerrier, et al.
Genetic Testing|August 16, 2002
Spectrum of MECP2 mutations in Rett syndromeThierry Bienvenu, Laurent Villard, Nicolas De Roux, et al.
European Journal of Human Genetics : EJHG|October 28, 2004
Mutation in the 5' alternatively spliced region of the XNP/ATR-X gene causes Chudley-Lowry syndromeFatima E Abidi, Carlos Cardoso, Anne-Marie Lossi, et al.
Orphanet Journal of Rare Diseases|May 8, 2015
CMTX1 patients' cells present genomic instability corrected by CamKII inhibitorsSaleh Mones, Burkhardt Gess, Benoit Bordignon, et al.
The Lancet. Neurology|October 13, 2009
Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trialJoëlle Micallef, Shahram Attarian, Odile Dubourg, et al.
Pageof 1